AirSculpt Technologies, Inc. (AIRS)
USD 5.85
(-7.0%)
USD 5.85
(-7.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.47 Million USD | 69.49% |
| 2022 | -14.67 Million USD | -239.12% |
| 2021 | 10.55 Million USD | 83.5% |
| 2020 | 5.75 Million USD | 213.03% |
| 2019 | -5.08 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -3.2 Million USD | -153.18% |
| 2024 Q1 | 6.02 Million USD | 231.81% |
| 2023 Q2 | 1.77 Million USD | 12785.71% |
| 2023 Q1 | -14 Thousand USD | 99.81% |
| 2023 FY | -4.47 Million USD | 69.49% |
| 2023 Q4 | -4.57 Million USD | -174.39% |
| 2023 Q3 | -1.66 Million USD | -193.86% |
| 2022 Q1 | -693 Thousand USD | 91.59% |
| 2022 Q3 | -7.37 Million USD | -1365.35% |
| 2022 Q2 | 583 Thousand USD | 184.13% |
| 2022 FY | -14.67 Million USD | -239.12% |
| 2022 Q4 | -7.19 Million USD | 2.51% |
| 2021 Q2 | 10.02 Million USD | 51.44% |
| 2021 FY | 10.55 Million USD | 83.5% |
| 2021 Q4 | -8.24 Million USD | -234.67% |
| 2021 Q3 | 6.12 Million USD | -38.95% |
| 2021 Q1 | 6.62 Million USD | 56.34% |
| 2020 Q4 | 4.23 Million USD | 74.78% |
| 2020 Q3 | 2.42 Million USD | 633.7% |
| 2020 Q2 | -454 Thousand USD | 0.0% |
| 2020 Q1 | -454 Thousand USD | 0.0% |
| 2020 FY | 5.75 Million USD | 213.03% |
| 2019 FY | -5.08 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 79.328% |
| Addus HomeCare Corporation | 62.51 Million USD | 107.165% |
| Amedisys, Inc. | -9.74 Million USD | 54.047% |
| American Oncology Network, Inc. | -5.54 Million USD | 19.181% |
| Astrana Health, Inc. | 60.71 Million USD | 107.377% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 96.67% |
| IMAC Holdings, Inc. | - USD | Infinity% |
| biote Corp. | 3.31 Million USD | 235.072% |
| Cryo-Cell International, Inc. | -9.52 Million USD | 52.96% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 106.167% |
| COMPASS Pathways plc | -118.46 Million USD | 96.219% |
| DocGo Inc. | 6.85 Million USD | 165.306% |
| The Ensign Group, Inc. | 209.39 Million USD | 102.139% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 111.668% |
| InnovAge Holding Corp. | -21.33 Million USD | 79.009% |
| Assure Holdings Corp. | -26.07 Million USD | 82.825% |
| The Joint Corp. | -9.75 Million USD | 54.072% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 97.595% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 71.294% |
| ModivCare Inc. | -204.46 Million USD | 97.809% |
| NewGenIvf Group Limited | 130.19 Thousand USD | 3540.277% |
| Novo Integrated Sciences, Inc. | -13.21 Million USD | 66.106% |
| Option Care Health, Inc. | 267.09 Million USD | 101.677% |
| P3 Health Partners Inc. | -57.77 Million USD | 92.247% |
| P3 Health Partners Inc. | -57.77 Million USD | 92.247% |
| The Pennant Group, Inc. | 13.37 Million USD | 133.478% |
| Surgery Partners, Inc. | -11.9 Million USD | 62.361% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | -52.433% |
| Talkspace, Inc. | -19.18 Million USD | 76.65% |
| Talkspace, Inc. | -19.18 Million USD | 76.65% |
| The Oncology Institute, Inc. | -83.06 Million USD | 94.608% |
| The Oncology Institute, Inc. | -83.06 Million USD | 94.608% |